login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Serotonin levels can be detected and measured through an innovative device called WINCS


Monday, 07 Feb 2011 14:31

Mayo Clinic researchers have concluded that, through deep brain stimulation, a Wireless Instantaneous Neurotransmitter Concentration System (WINCS) can detect and measure serotonin levels in the brain. The findings suggest that in the future such measurements of serotonin may help establish a therapeutic mechanism of deep brain stimulation for psychiatric disease. This study was published in the September 2010 issue of the Journal of Neurosurgery.


Serotonin is a neurotransmitter in the brain that is thought to play a key role in controlling depression, the second most disabling condition in the developed world, with lifetime prevalence in the United States of 17%. Using deep brain stimulation, neurosurgeons can help patients with essential tremor, Parkinson’s disease, movement disorders, and now, based on this study, psychiatric disorders.


“In a previous study, in order to better understand the mechanism of deep brain stimulation, we created WINCS, a new device that successfully measured such neurotransmitter levels as dopamine and norepinephrine on a second-by-second basis,” said Kendall Lee, neurosurgeon at Mayo Clinic. “In this experiment, we wanted to try to measure serotonin, which is very important in the mechanism of depression and its treatment. This study shows that WINCS can measure serotonin with a technology called fast-scan cyclic voltammetry, which is an electrochemical method of being able to measure serotonin in real time in the living brain,” Kendall added.

Researchers collaborated with Mayo Clinic’s division of Engineering and Paul Garris, at Illinois State University, who helped design and test the WINCS device. “We were able to take the laboratory method of neurotransmitter detection and create a miniaturised, wireless, computer-controlled device that allowed the detection to occur in real time,” says Kevin Bennet, chair, Mayo Clinic’s division of Engineering “We took the technique of fast-scan cyclic voltammetry, created real-time control and reporting, and converted it into something that can be used in animals and humans.”

“Using this device, we can now do real-time serotonin measurement, so we are hopeful that in the near future we are able to use WINCS to measure serotonin in the human brain,”  said Lee “What is significant is that if we can measure serotonin, perhaps we can modulate it. This opens the door for even more exciting areas of medicine. By having technology such as WINCS, rather than just diagnosing or measuring neurotransmitters, you can use this as a therapeutic tool to more precisely regulate brain neurotransmitter levels.”




Add New Comment

Most popular


MR CLEAN: expert opinion
Tuesday, 18 Nov 2014
Since the first presentation of data at the World Stroke Congress, the MR CLEAN trial has sent a ripple across the entire neurointerventional arena, raising questions about the future of stroke ... MR CLEAN: expert opinion

MR CLEAN: Better outcomes with intervention in ischaemic stroke patients
Thursday, 18 Dec 2014
For the first time, the Multicentre randomised clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands (MR CLEAN) has shown better outcomes in favour of intervention in ... MR CLEAN: Better outcomes with intervention in ischaemic stroke patients

Silk Road Medical unveils data from the ROADSTER trial
Wednesday, 26 Nov 2014
Silk Road Medical’s 30-day outcomes from the ROADSTER IDE study were presented at the Late Breaking Clinical Trials Session at the 2014 Vascular InterVentional Advances Meeting in Las Vegas, with ... Silk Road Medical unveils data from the ROADSTER trial

Features


Impact“ful” moments
Friday, 05 Dec 2014
Once a year, in almost ritualised fashion, the editors of peer-reviewed journals anxiously await publication of the Thomson Reuters Impact Factor. Journals in the “neuro” space are no exception to ... Impact“ful” moments

The changing face of traumatic brain injury: Life beyond the guidelines
Tuesday, 18 Nov 2014
András Büki and Andrew Maas write that despite considerable efforts both in basic and clinical research, there has not been a major breakthrough in the care of the head injured in the last three ... The changing face of traumatic brain injury: Life beyond the guidelines

Profiles


Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Mauricio Castillo
Monday, 14 Jul 2014
Mauricio Castillo is a professor of Radiology and chief, Division of Neuroradiology, University of N... Mauricio Castillo

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions